09:42 AM EST - Doseology Sciences Inc. : Formally announces the addition of Dr. Olivier Wellman-Labadie to its growing team of mycologists and researchers. Dr. Olivier Wellman-Labadie will perform the duties required by the Health Canada Controlled Drugs and Substances Dealer's Licence and contribute to the development of psilocybin research and mushroom production. Since 2007, Dr. Wellman-Labadie has co-authored twelve research papers in the field of molecular biology. Doseology Sciences Inc.
shares C.MOOD are trading unchanged at $0.15.
